| Title |
What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
|
|---|---|
| Published in |
Journal of Patient-Reported Outcomes, August 2020
|
| DOI | 10.1186/s41687-020-00218-5 |
| Pubmed ID | |
| Authors |
Rachael Lawrance, Evgeny Degtyarev, Philip Griffiths, Peter Trask, Helen Lau, Denise D’Alessio, Ingolf Griebsch, Gudrun Wallenstein, Kim Cocks, Kaspar Rufibach |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 20% |
| United States | 2 | 13% |
| Australia | 1 | 7% |
| Canada | 1 | 7% |
| Unknown | 8 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 60% |
| Scientists | 3 | 20% |
| Practitioners (doctors, other healthcare professionals) | 2 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 69 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 13 | 19% |
| Researcher | 12 | 17% |
| Student > Master | 6 | 9% |
| Student > Doctoral Student | 3 | 4% |
| Student > Bachelor | 3 | 4% |
| Other | 10 | 14% |
| Unknown | 22 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 23% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 10% |
| Mathematics | 6 | 9% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Social Sciences | 2 | 3% |
| Other | 12 | 17% |
| Unknown | 23 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2024.
All research outputs
#2,470,224
of 24,273,038 outputs
Outputs from Journal of Patient-Reported Outcomes
#31
of 578 outputs
Outputs of similar age
#64,365
of 403,125 outputs
Outputs of similar age from Journal of Patient-Reported Outcomes
#4
of 27 outputs
Altmetric has tracked 24,273,038 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 578 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 403,125 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.